Endothelial Cell News Volume 6.14 | Apr 26 2021

    0
    48







    2021-04-26 | ENDOCN 6.14


    Endothelial Cell News by STEMCELL Technologies
    Vol. 6.14 – 26 April, 2021
    TOP STORY

    Transcriptomic Analysis of CFTR-Impaired Endothelial Cells Reveals a Pro-Inflammatory Phenotype

    Investigators used an unbiased RNA sequencing approach in complementary models of cystic fibrosis transmembrane conductance regulator (CFTR) silencing and blockade in human endothelial cells to characterise the changes upon CFTR impairment.
    [European Respiratory Journal]

    Abstract
    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    PUBLICATIONSRanked by the impact factor of the journal

    Loss of Endothelial Glucocorticoid Receptor Accelerates Diabetic Nephropathy

    The fibrogenic phenotype in the kidneys of diabetic mice lacking endothelial glucocorticoid receptor was associated with aberrant cytokine and chemokine reprogramming, augmented Wnt signaling and suppression of fatty acid oxidation.
    [Nature Communications]

    Full Article

    Disruption of the Blood−Brain Barrier in 22q11.2 Deletion Syndrome

    Researchers investigated whether the neuroimmune dysregulation vascular phenotype was intrinsically compromised in the most common genetic risk factor for schizophrenia, the 22q11.2 deletion syndrome.
    [Brain]

    Full ArticlePress Release

    LncRNA GAS5 Activates the HIF1A/VEGF Pathway by Binding to TAF15 to Promote Wound Healing in Diabetic Foot Ulcers

    Scientists aimed to investigate the role of GAS5 in wound healing in diabetic foot ulcer as well as the underlying mechanism.
    [Laboratory Investigation]

    Abstract

    Contribution of PDGFRα-Positive Cells in Maintenance and Injury Responses in Mouse Large Vessels

    The authors utilized a lineage tracing model of platelet-derived growth factor receptor alpha (PDGFRa) cells and examined cellular behavior during homeostasis and injury response.
    [Scientific Reports]

    Full ArticleEditorial

    Nrf2/HO-1 Axis Regulates the Angiogenesis of Gastric Cancer via Targeting VEGF

    The expression of nuclear factor-erythroid 2-related factor 2 (Nrf2), heme oxygenase 1 (HO-1), and VEGF in BGC-823 cells under hypoxia was analyzed using immunocytochemistry, immunofluorescence, Western blotting, and quantitative PCR.
    [Cancer Management and Research]

    Full Article

    A Novel Hypothesis and Characterization to Isolate Microvascular Endothelial Cells Simultaneously with Adipose-Derived Stem Cells from the Human Adipose-Derived Stromal Vascular Fraction

    To isolate adipose-derived human microvascular endothelial cells, scientists analyzed the supernatant discarded when adipose stem cells were isolated from the adipose-derived stromal vascular fraction.
    [Tissue Engineering and Regenerative Medicine]

    Abstract

    Apatinib Suppresses the Migration, Invasion and Angiogenesis of Hepatocellular Carcinoma Cells by Blocking VEGF and PI3K/AKT Signaling Pathways

    Apatinib was used to treat hepatocellular carcinoma (HCC) cells transfected with or without VEGFR2 overexpression vectors. The proliferation of HCC cells was detected by MTT assay.
    [Molecular Medicine Reports]

    Full Article
    Microscopy images of pluripotent stem cells (PSCs) and PSC-derived cells for the #StemCellfie contest.
    REVIEWS

    MicroRNAs and Angiogenesis: A New Era for the Management of Colorectal Cancer

    Investigators describe the latest advances in the understanding of miRNAs and their corresponding targets that play a role in colorectal cancer angiogenesis and discuss possible miRNA-based therapeutic strategies.
    [Cancer Cell International]

    Full Article

    Vascular Anomalies of the Head and Neck: Diagnosis and Treatment

    The authors discuss the diagnosis and management of the most common intracranial and extracranial vascular malformations and tumors in the head and neck in children and adolescents.
    [Pediatric Radiology]

    Abstract
    INDUSTRY AND POLICY NEWS

    D&D Pharmatech Announces Sponsored Research Agreement with Yale University to Optimize Novel Strategies for the Treatment of Brain Cancer and Other Diseases of the Central Nervous System

    D&D Pharmatech, Inc. announced it has entered into a sponsored research agreement with Yale University relating to optimization of two novel approaches that allow immune system cells and drug molecules to bypass the blood-brain barrier for the treatment of brain cancer and other disorders.
    [D&D Pharmatech, Inc. (Business Wire, Inc.))]

    Press Release

    Humacyte Announces Positive Long-Term Follow-Up Data from Phase II Vascular Access Trial

    Humacyte, Inc. announced that five-year data from a Phase II clinical trial of patients receiving the human acellular vessels (HAV) for arteriovenous access in hemodialysis suggest the long-term durability and functional hemodialysis access of the HAV.
    [Humacyte, Inc. (GlobeNewswire, Inc.)]

    Press Release
    FEATURED EVENT

    3D Cell Culture 2021: Models, Applications & Translation

    May 5 – 7, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Vascular Cell Signaling

    LSU Health Science Center – Shreveport, Louisianam United States

    Postdoctoral Position – Angiogenesis and Vascular Heterogeneity

    Aarhus University – Copenhagen, Denmark

    Postdoctoral Position – Neuronal and Endothelial Cell Relations

    Icahn School of Medicine at Mount Sinai – New York, New York, United States

    Postdoctoral Fellow – Endothelial Cell Ion Channels

    The University of Tennessee Health Science Center – Memphis, Tennessee, United States

    Postdoctoral Fellow – Vascular Networks

    Boston Children’s Hospital – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Endothelial Cell News Twitter